Meril Secures $200M Investment from ADIA, Valuing Company at $6.6B
Meril, a prominent global medical technology company, has received a substantial investment from a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA). The $200 million investment values Meril at an enterprise value of $6.6 billion and gives ADIA a roughly 3% stake in the company.
Founded in India, Meril has expanded rapidly, employing over 13,000 people and establishing 35 global subsidiaries. It serves healthcare systems in over 150 countries, empowering more than 10,000 healthcare professionals annually through its 12+ global training academies. The company's state-of-the-art, vertically integrated manufacturing facilities in Vapi, India, span a sustainable 100-acre campus.
Meril focuses on clinically advanced solutions across multiple specialties, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics. Its in-house global R&D ecosystem and portfolio of 200+ technology platforms are set to be bolstered by ADIA's investment. Sanjeev Bhatt, Senior Vice President - Strategy at Meril, believes the investment will accelerate growth, attract top talent, and strengthen R&D and clinical research efforts.
The transaction, subject to regulatory approval by the Competition Commission of India (CCI), will see Meril backed by two globally recognized investors, ADIA and Warburg Pincus. This investment underscores Meril's potential and commitment to advancing medical technology worldwide.
Read also:
- Overweight women undergoing IVF have a 47% higher chance of conceiving naturally post-weight loss
- Bonsai Trees from Evergreen Species: Exploring Growth Characteristics & Distinct Qualities
- What temperatures may make walking your canine companion uncomfortable?
- Title: Information About Beovu: Potency, Form, Usage, and Additional Details
